John G. Lemkey, Officer, Chief Executive Officer, Chief Financial Officer, Chief Operating Officer at Odonate Therapeutics, Inc. (ODT), bought 769,231 shares at $26.00 ($20.0M) on 2019-06-26, disclosed to the SEC on 2019-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ODT | BUY | 2018-12-26 | $756K | — | Filing → |
| ODT | BUY | 2018-12-18 | $848K | — | Filing → |
| ODT | BUY | 2018-10-25 | $919K | — | Filing → |